Friday, July 10, 2026

pharma · Chronic Hepatitis D Infection · Chronic Hepatitis Delta Infection

Blue Earth Diagnostics

Blue Earth Diagnostics is a pharma organization headquartered in GB. Primary therapeutic focus areas include Chronic Hepatitis D Infection, Chronic Hepatitis Delta Infection, PSMA-positive non-curative metastatic castrat

Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, GB HQ
2014 Founded
120 Employees
EMA registrant Type
Company details
Status
Public
HQ
Magdalen Centre, The Oxford Science Park, Oxford, OX4 4GA, GB
Founded
2014
Employees
120
Programs
11
Drugs
12
Patents
0
Clinical program

BFB759, Placebo

Phase 2 · small molecule · Atopic dermatitis

BFB759, Placebo for Atopic dermatitis is a Phase 2 program (small_molecule) at Blue Earth Diagnostics Ireland Ltd with 1 ClinicalTrials.gov record(s).

Internal code CL-BFB759-002

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Blue Earth Diagnostics Ireland Ltd
Phase
Phase 2
Modality
small_molecule
Indication
Atopic dermatitis
Status
active
Trials
1

Clinical trials